Healthcare provider profile · identity verified

Jennifer Sepp

Family Practice · DELMONT, PA · NPI 1700855731

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	552	136
Atorvastatin Calcium	Atorvastatin Calcium	503	141
Rosuvastatin Calcium	Rosuvastatin Calcium	462	133
Lisinopril	Lisinopril	355	107
Omeprazole	Omeprazole	281	78
Losartan Potassium	Losartan Potassium	277	73
Gabapentin	Gabapentin	229	53
Amlodipine Besylate	Amlodipine Besylate	211	65
Metformin Hcl	Metformin Hcl	194	48
Sertraline Hcl	Sertraline Hcl	185	43
Pantoprazole Sodium	Pantoprazole Sodium	182	51
Jardiance	Empagliflozin	179	39
Escitalopram Oxalate	Escitalopram Oxalate	176	46
Olmesartan Medoxomil	Olmesartan Medoxomil	164	40
Ezetimibe	Ezetimibe	163	47
Metformin Hcl Er	Metformin Hcl	161	49
Famotidine	Famotidine	157	54
Metoprolol Succinate	Metoprolol Succinate	152	46
Hydrochlorothiazide	Hydrochlorothiazide	148	44
Fluoxetine Hcl	Fluoxetine Hcl	143	33
Furosemide	Furosemide	137	36
Buspirone Hcl	Buspirone Hcl	136	29
Duloxetine Hcl	Duloxetine Hcl	135	25
Metoprolol Tartrate	Metoprolol Tartrate	128	35
Albuterol Sulfate Hfa	Albuterol Sulfate	119	42
Montelukast Sodium	Montelukast Sodium	116	29
Ibandronate Sodium	Ibandronate Sodium	114	19
Fluticasone Propionate	Fluticasone Propionate	97	34
Potassium Chloride	Potassium Chloride	96	25
Allopurinol	Allopurinol	94	22
Alendronate Sodium	Alendronate Sodium	92	27
Pravastatin Sodium	Pravastatin Sodium	90	29
Simvastatin	Simvastatin	90	31
Estradiol	Estradiol	88	53
Trulicity	Dulaglutide	86	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	19
Eliquis	Apixaban	81	16
Atenolol	Atenolol	80	23
Alprazolam	Alprazolam	74	17
Clonazepam	Clonazepam	74	11
Trazodone Hcl	Trazodone Hcl	73	23
Synthroid	Levothyroxine Sodium	71	19
Carvedilol	Carvedilol	70	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	22
Topiramate	Topiramate	63	11
Ozempic	Semaglutide	62	15
Pregabalin	Pregabalin	61	11
Lorazepam	Lorazepam	58	20
Prednisone	Prednisone	56	36
Meloxicam	Meloxicam	55	19
Bupropion Hcl Sr	Bupropion Hcl	54	14
Bupropion Xl	Bupropion Hcl	51	12
Breo Ellipta	Fluticasone/Vilanterol	48	suppressed
Celecoxib	Celecoxib	46	16
Doxepin Hcl	Doxepin Hcl	45	12
Warfarin Sodium	Warfarin Sodium	45	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	44	12
Clopidogrel	Clopidogrel Bisulfate	43	15
Ropinirole Hcl	Ropinirole Hcl	42	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Ondansetron Hcl	Ondansetron Hcl	38	16
Ventolin Hfa	Albuterol Sulfate	37	15
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	12
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Valsartan	Valsartan	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	13
Mirtazapine	Mirtazapine	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Glipizide Er	Glipizide	30	14
Mounjaro	Tirzepatide	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Amoxicillin	Amoxicillin	28	22
Lovastatin	Lovastatin	28	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Ibuprofen	Ibuprofen	27	15
Tramadol Hcl	Tramadol Hcl	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	12
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	11
Mupirocin	Mupirocin	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	21
Chlorthalidone	Chlorthalidone	24	suppressed
Nystatin	Nystatin	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Jantoven	Warfarin Sodium	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Ibu	Ibuprofen	21	suppressed
Azithromycin	Azithromycin	20	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Enalapril Maleate	Enalapril Maleate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Baclofen	Baclofen	16	suppressed
Temazepam	Temazepam	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Glipizide	Glipizide	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Guanfacine Hcl	Guanfacine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error